Hourly refreshSun, Oct 25, 2026

Press Release Database

Recent press releases, indexed by topic.
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
Results
Showing all · English · 37,778 itemsDownloadExcelTXT
Gaming

Building the Ultimate Game Night: Domino's® and Minecraft Dungeons II Team Up for a Block-Shaped Collaboration

Customers who purchase a Domino™ can unlock exclusive in-game items and experiences that bridge the worlds of gaming and pizza, starting on Oct. 26 Key highlights: Domino's is rolling out six collectible Minecraft Dungeons II-themed boxes and exclusive in-game items* for Minecraft Dungeon...

Oct 21 · 11:07PR Newswire
Real estate

PRG Real Estate's Dana Dobrowolski Named First Runner-Up in Grace Hill's 2026 Impact Hero Awards

Director of Accounting recognized for her commitment to Team Foster, a nonprofit organization that provides service dogs to veterans with disabilities PHILADELPHIA, Oct. 21, 2026 -- Dana Dobrowolski, Director of Accounting at PRG Real Estate, has been named first runner-up in...

Oct 21 · 11:05PR Newswire
Finance

Trimble Third Quarter Earnings Call and Webcast

WESTMINSTER, Colo., Oct. 21, 2026 -- Trimble (Nasdaq: TRMB) will hold a conference call on Wednesday, November 4, 2026 at 8 a.m. ET to review its third quarter 2026 results. The call will be broadcast live on the web at https://events.q4inc.com/attendee/824595803. Analysts...

Oct 21 · 11:05PR Newswire
Biotech & pharma

Nanoscope Therapeutics Announces Publication of Preclinical Data Showing Targeted, Durable Vision Restoration with OCT-Guided, Non-Viral Gene Delivery

Optical coherence tomography (OCT)-guided nano-enhanced optical delivery (NOD) delivered multi-characteristic opsin (MCO) genes to precisely selected regions of the retina without a viral vector A single treatment produced retinal and cortical light responses that were sustained for up to...

Oct 21 · 11:05PR Newswire
Finance · Healthcare

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027

MOUNTAIN VIEW, Calif., Oct. 21, 2026 -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The NDA was resubmitted following a Complete Response Letter (CRL) received in June 2026. The FDA has deemed the OLC resubmission a Class II with a six-month review period from the resubmission date, and set a Prescription Drug User Fee Act (PDUFA) target action date of March 25, 2027.

Oct 21 · 11:05GlobeNewswire
Automotive · Aerospace & defense

SAFE Structure Designs Awarded Contract for Custom CH-47 Wraparound Maintenance Platforms for Minnesota Army National Guard

Helicopter fall protection platforms tailored to the maintenance team's requirements emphasize aircraft access, mobility, and efficient use of hangar space. LAS VEGAS, Oct. 21, 2026 -- S.A.F.E. Structure Designs LLC (SAFE) has been awarded a contract to supply a full set of...

Oct 21 · 11:04PR Newswire
Energy

WISDOMTREE WTI CRUDE OIL 3X DAILY SHORT SECURITIES ISIN: XS2819844387 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES MEETING OF THE ETP SECURITYHOLDERS

21 October 2026

Oct 21 · 11:04GlobeNewswire
Industrial

Austin Roofing Awarded Major Steel Roof Restoration at Parts Canada Corporate Headquarters in London, Ontario

LONDON, Ontario, Oct. 21, 2026 -- Austin Roofing & Waterproofing Incorporated, recognized as Canada’s largest commercial and industrial roofing coatings contractor, has secured another major industrial steel roof restoration project at the Parts Canada corporate headquarters in London, Ontario.

Oct 21 · 11:03GlobeNewswire
In the wire

Form 8.3 - Brave Bison Group Plc

Downing LLP LEI: 213800G3X76VBG9SB504 21 October 2026 Form 8.3 re. Brave Bison Group Plc

Oct 21 · 11:03GlobeNewswire
In the wire

New Days on the Roof of the World: Four Elders on 75 Years of Change in Xizang

RIKAZE, China, Oct. 21, 2026 -- A report from People's Daily. Only those who have borne the bitter cold can savour spring's gentle warmth. Puciren was born in 1944 in Rikaze, Xizang, and spent his boyhood under a serf owner's roof. After the peaceful liberation of Xizang in...

Oct 21 · 11:02PR Newswire
In the wire

Global Deep-Sea Scientific and Technological Innovation Forces to Gather in Hainan, China

Hainan Provincial Department of Science and Technology Hainan Provincial Department of Science and Technology

Oct 21 · 11:02GlobeNewswire
Finance · Biotech & pharma

Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026

NEW HAVEN, Conn., Oct. 21, 2026 -- Invivyd, Inc. (Nasdaq: IVVD) today announced the presentation of preclinical data describing its novel, potential first- and best-in-class investigational monoclonal antibody candidate VMS063 at IDWeek 2026™ in Washington, D.C. Data demonstrated highly potent in vitro antiviral activity against contemporary measles fusion protein (MeV-F) variants, supporting its potential utility for both treatment and prevention (pre/post-exposure prophylaxis) of measles.

Oct 21 · 11:01GlobeNewswire